The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America

Compared to a decade ago, nearly three times as many drugs for rare diseases are slated for development. This article addresses the market access issues associated with orphan drug status in Europe and the United States in contrast to the legislation in five Latin American (LA) countries that have m...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Renée J.G., Bighash, Lida, Bryón Nieto, Alejandro, Tannus Branco de Araújo, Gabriela, Gay-Molina, Juan Gabriel, Augustovski, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2015
Materias:
Opinion Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367514/
https://www.ncbi.nlm.nih.gov/pubmed/25844162
http://dx.doi.org/10.12688/f1000research.4268.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367514/
https://www.ncbi.nlm.nih.gov/pubmed/25844162
http://dx.doi.org/10.12688/f1000research.4268.1

Ejemplares similares